About The BSW APC
APC Recent Decisions October 2020
Omeprazole Oxybutynin Over active bladder Oab Anticholinergic True metrix Blood glucose Monitoring Coaguchek INR Sharps Cmpa Milk Decapeptyl Lhrh Eloine Entacapone Perinatal
NHS BSW CCG Managing male patients with prostate cancer on LHRH analogues during COVID-19 pandemic
LHRH goserelin leuprorelin prostate decapeptyl zoladex prostap
Guidelines for the Pharmacological Management of Overactive Bladder Disease in Adults in Primary Care October 2020
Overactive Bladder (OAB) Mirabegron NICE TA290 Betmiga Regurin Vesicare Detrunorm Detrusitol Lyrinel Toviaz Fesoteradine Ditropan Tolterodine Oxybutynin Oxybutynin MR Trospium Solifenacin Mirabegron
APC Recent Decisions September 2020
Memantine orodispersible tablets Fulvestrant Patiromer Polystyrene resins Danazol
BSW APC Terms of Reference
APC Purpose responsibilities membership committee TOR meetings Quoracy reporting conduct
BSW APC Technical Group Terms of Reference
APC technical group Terms of reference TOR Membership reporting
BSW Management of Infection Guidance for Primary Care December 2020 update
Antibiotic Delayed Antibiotic c.difficile UPPER RESPIRATORY TRACT INFECTIONS LOWER RESPIRATORY TRACT INFECTIONS MENINGITIS URINARY TRACT INFECTIONS GENITAL TRACT INFECTIONS GASTRO-INTESTINAL TRACT INFECTIONS SKIN INFECTIONS EYE… Read More »BSW Management of Infection Guidance for Primary Care December 2020 update
- « Previous
- 1
- 2
- 3
- Next »